UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine

Current medical research and opinion, 2014-08, Vol.30 (8), p.1673-1685

2014

Volltextzugriff (PDF)

Patient experiences with FVIII products: differences in wastage, vial numbers and preparation time

Journal of drug assessment (London, U.K.), 2018-09, Vol.7 (sup1), p.13-13

2018

Volltextzugriff (PDF)

Variation in Treatment Patterns and Outcomes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Across European Countries

Value in health, 2013-11, Vol.16 (7), p.A552-A552

2013

Volltextzugriff (PDF)

PMH37 Systematic Review of Health State Utilities in Attention Deficit Hyperactivity Disorder (ADHD)

Value in health, 2012-11, Vol.15 (7), p.A340-A340

2012

Volltextzugriff (PDF)

PMH5 Systematic Review and Network Meta-Analysis of Treatments Used for Attention Deficit Hyperactivity Disorder (ADHD)

Value in health, 2012-11, Vol.15 (7), p.A334-A334

2012

Volltextzugriff (PDF)

1041 – The incidence, resource utilization and financial costs of treating children with attention deficit/hyperactivity disorder (ADHD) in the united kingdom (UK)

European psychiatry, 2013, Vol.28, p.1-1

2013

Volltextzugriff (PDF)

Comparison of Health Care Resource Utilization and Costs Among Children and Adolescents with Attention Deficit Hyperactivity Disorder in Germany Who Initiated Treatment with Atomoxetine or Long-Acting Methylphenidate

Value in health, 2013-11, Vol.16 (7), p.A549-A550

2013

Volltextzugriff (PDF)

Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

Value in health, 2013-11, Vol.16 (7), p.A549-A549

2013

Volltextzugriff (PDF)

PMH58 The Impact of ADHD Medication Attributes on Physician Prescribing Behavior in the EU: Results From Chart-Reviewed Data

Value in health, 2012-11, Vol.15 (7), p.A344-A344

2012

Volltextzugriff (PDF)

Development of a conceptual disease model to inform strategy to evaluate treatment impact in adolescents with attention deficit hyperactivity disorder (ADHD)

Value in health, 2013-05, Vol.16 (3), p.A64-A65

2013

Volltextzugriff (PDF)

EPA-0993 – Health utility scores in children and adolescents with attention-deficit/hyperactivity disorder: response to stimulant treatment

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

PDB46 DEVELOPMENT OF THE DIABETIC PERIPHERAL NEUROPATHIC PAIN IMPACT MEASURE: A PATIENT-REPORTED OUTCOME MEASURE OF THE IMPACT OF DPNP ON FUNCTIONING

Value in health, 2011, Vol.14 (3), p.A99-A99

2011

Volltextzugriff (PDF)

PDB45 THE PATIENT REPORTED EXPERIENCE OF LIVING WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN (DPNP)

Value in health, 2011, Vol.14 (3), p.A99-A99

2011

Volltextzugriff (PDF)

PMH65 Comparison of Deviation Rates from the Labeled Daily Average Consumption in Patients Initiated on Stimulant Medication for the Treatment of Attention-Deficit/Hyperactivity Disorder

Value in health, 2012-06, Vol.15 (4), p.A93-A93

2012

Volltextzugriff (PDF)

P-876 - Adult adhd patients’ experiences of impairment, accessing services and treatment management - a qualitative study in England

European psychiatry, 2012, Vol.27, p.1-1

2012

Volltextzugriff (PDF)

PCR39 Exploring Patient and Caregiver Perspectives on Burden Associated with Friedreich Ataxia in the USA

Value in health, 2024-06, Vol.27 (6), p.S303-S303

2024

Volltextzugriff (PDF)

PRS25 FACTORS INFLUENCING SATISFACTION WITH COPD MAINTENANCE MEDICATION: CONCEPTS ELICITED THROUGH QUALITATIVE INTERVIEWS WITH PATIENTS

Value in health, 2011, Vol.14 (3), p.A141-A141

2011

Volltextzugriff (PDF)

UT4 Health Utility Scores in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Response to Stimulant Treatment

Value in health, 2012-11, Vol.15 (7), p.A284-A284

2012

Volltextzugriff (PDF)

RWD46 Real-World Clinical Burden of Friedreich Ataxia in the United States

Value in health, 2024-06, Vol.27 (6), p.S365-S365

2024

Volltextzugriff (PDF)

POSA96 The Economic Burden of Thromboembolic Events (TE) Among Patients with Inflammatory Bowel Disease (IBD)

Value in health, 2022-01, Vol.25 (1), p.S52-S52

2022

Volltextzugriff (PDF)

PRS51 The Development of the Early Morning Symptoms of COPD Instrument (EMSCI)

Value in health, 2011, Vol.14 (7), p.A496-A497

2011

Volltextzugriff (PDF)

PMU8 The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases

Value in health, 2021-06, Vol.24, p.S146-S146

2021

Volltextzugriff (PDF)

P157 Patient-reported disease activity in a large sample of ulcerative colitis patients using social media-delivered questionnaires

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S216-S217

2020

Volltextzugriff (PDF)

PMH63 - Variation in Treatment Patterns and Outcomes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Across European Countries

Value in health, 2013-11, Vol.16 (7), p.A552-A552

2013

Volltextzugriff (PDF)

PMH47 - Comparison of Health Care Resource Utilization and Costs Among Children and Adolescents with Attention Deficit Hyperactivity Disorder in Germany Who Initiated Treatment with Atomoxetine or Long-Acting Methylphenidate

Value in health, 2013-11, Vol.16 (7), p.A549-A550

2013

Volltextzugriff (PDF)

1 – 25 von 223

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(172)

Publikationsform

Sprache

Englisch
(222)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Technology
(56)
Materials Science
(49)
Materials Science, Multidisciplinary
(44)
Physics
(28)
Physical Sciences
(24)
Science & Technology - Other Topics
(21)
Life Sciences & Biomedicine
(20)
Internal Medicine
(17)
Tungsten
(15)
Metallurgy & Metallurgical Engineering
(14)
Nuclear Science & Technology
(14)
Nanoscience & Nanotechnology
(13)
Humans
(12)
Physics, Applied
(12)
Engineering
(9)
Mechanical Properties
(9)
Molecular Dynamics
(9)
Chemistry
(8)
Computer Simulation
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine

Patient experiences with FVIII products: differences in wastage, vial numbers and preparation time

Variation in Treatment Patterns and Outcomes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Across European Countries

PMH37 Systematic Review of Health State Utilities in Attention Deficit Hyperactivity Disorder (ADHD)

PMH5 Systematic Review and Network Meta-Analysis of Treatments Used for Attention Deficit Hyperactivity Disorder (ADHD)

1041 – The incidence, resource utilization and financial costs of treating children with attention deficit/hyperactivity disorder (ADHD) in the united kingdom (UK)

Comparison of Health Care Resource Utilization and Costs Among Children and Adolescents with Attention Deficit Hyperactivity Disorder in Germany Who Initiated Treatment with Atomoxetine or Long-Acting Methylphenidate

Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

PMH58 The Impact of ADHD Medication Attributes on Physician Prescribing Behavior in the EU: Results From Chart-Reviewed Data

Development of a conceptual disease model to inform strategy to evaluate treatment impact in adolescents with attention deficit hyperactivity disorder (ADHD)

EPA-0993 – Health utility scores in children and adolescents with attention-deficit/hyperactivity disorder: response to stimulant treatment

PDB46 DEVELOPMENT OF THE DIABETIC PERIPHERAL NEUROPATHIC PAIN IMPACT MEASURE: A PATIENT-REPORTED OUTCOME MEASURE OF THE IMPACT OF DPNP ON FUNCTIONING

PDB45 THE PATIENT REPORTED EXPERIENCE OF LIVING WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN (DPNP)

PMH65 Comparison of Deviation Rates from the Labeled Daily Average Consumption in Patients Initiated on Stimulant Medication for the Treatment of Attention-Deficit/Hyperactivity Disorder

P-876 - Adult adhd patients’ experiences of impairment, accessing services and treatment management - a qualitative study in England

PCR39 Exploring Patient and Caregiver Perspectives on Burden Associated with Friedreich Ataxia in the USA

PRS25 FACTORS INFLUENCING SATISFACTION WITH COPD MAINTENANCE MEDICATION: CONCEPTS ELICITED THROUGH QUALITATIVE INTERVIEWS WITH PATIENTS

UT4 Health Utility Scores in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Response to Stimulant Treatment

RWD46 Real-World Clinical Burden of Friedreich Ataxia in the United States

POSA96 The Economic Burden of Thromboembolic Events (TE) Among Patients with Inflammatory Bowel Disease (IBD)

PRS51 The Development of the Early Morning Symptoms of COPD Instrument (EMSCI)

PMU8 The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases

P157 Patient-reported disease activity in a large sample of ulcerative colitis patients using social media-delivered questionnaires

PMH63 - Variation in Treatment Patterns and Outcomes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Across European Countries

PMH47 - Comparison of Health Care Resource Utilization and Costs Among Children and Adolescents with Attention Deficit Hyperactivity Disorder in Germany Who Initiated Treatment with Atomoxetine or Long-Acting Methylphenidate

Suchergebnisse filtern